RNS Number : 0753F
GlaxoSmithKline PLC
05 January 2010
Notification of Transactions of Directors, Persons Discharging Managerial Responsibility or Connected Persons
I give below details of changes in the directors' interests in the Ordinary shares and American Depository Shares (ADSs) of GlaxoSmithKline plc.
On 31 December 2009, the Company's Non-Executive Directors were provisionally allocated awards over Ordinary shares at a price of £13.25 per Ordinary share and $42.40 per ADS under the share allocation arrangements for Non-Executive Directors for the period of service from 1 October 2009 to 31 December 2009:
|
Non Executive Director
|
Ordinary Shares
|
American Depository Shares (ADSs)
|
|
Sir Christopher Gent
|
2,547.17
|
|
|
|
|
|
|
Prof. Sir Roy Anderson
|
636.79
|
|
|
|
|
|
|
Dr Stephanie Burns
|
|
181.25
|
|
|
|
|
|
Mr Lawrence Culp
|
|
181.25
|
|
|
|
|
|
Sir Crispin Davis
|
2,358.49
|
|
|
|
|
|
|
Sir Deryck Maughan
|
|
181.25
|
|
|
|
|
|
Mr James Murdoch
|
495.28
|
|
|
|
|
|
|
Dr Daniel Podolsky
|
|
253.76
|
|
|
|
|
|
Mr Tom de Swaan
|
872.64
|
|
|
|
|
|
|
Sir Robert Wilson
|
636.79
|
|
The Company and the Non-Executive Directors were informed of these allocations on 4 January 2010.
This notification relates to transactions notified in accordance with Disclosure and Transparency Rule 3.1.4R(1)(a).
S M Bicknell
Company Secretary
5 January 2010
This information is provided by RNS
The company news service from the London Stock Exchange
END
RDSQELFBBFFXBBB